First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Sources of information and study methodology
Cerrar esta carpeta3. Dissemination and uptake of the Guidelines
Ver el documentoThe development stage: September 1994 - May 1996
Ver el documentoThe launch: May 1996
Ver el documentoAfter May 1996: dissemination of the Guidelines
Ver el documentoOther publications about drug donations
Ver el documentoConferences at which the Guidelines were discussed
Ver el documentoInternational organizations subscribing to the Guidelines
Ver el documentoCountries and national organizations that have adapted or adopted the Guidelines
Ver el documentoOther country studies on drug donations
Abrir esta carpeta y ver su contenido4. Basic characteristics of drug donations
Abrir esta carpeta y ver su contenido5. Practical benefits as a result of the Guidelines
Ver el documento6. Drug donations which were hampered, delayed or cancelled
Abrir esta carpeta y ver su contenido7. Experiences and opinions regarding the 12-month shelf-life requirement
Abrir esta carpeta y ver su contenido8. Other suggestions to improve the Guidelines
Abrir esta carpeta y ver su contenido9. How could donation practice be further improved?
Ver el documento10. Summary of recommendations
Ver el documento11. Postscript
Ver el documentoReferences
 

Other country studies on drug donations

The Association for Drug Information in the Republic of Moldova issued a questionnaire about the use of donated drugs among 600 health care professionals. Of the respondents, 21% reported that all drugs were used completely, 35% noted that drugs went into the illegal market, and 47% said that drugs were not used owing to unskilled distribution.

The Harvard School of Public Health in Boston initiated and completed a three-country study (Armenia, Haiti and the United Republic of Tanzania) on drug donations.4

In the Netherlands an evaluation study revealed that the number of pharmacists giving returned drugs to small-scale charity organizations for donation purposes dropped from approximately 70% in 1995 to 25% in 1998. A qualitative study among such organizations showed more awareness about the possible negative implications of using returned drugs for donations.

DIFÄM in Germany distributed an abbreviated questionnaire on drug donations to the 500 members on its mailing list. Results are awaited.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013